Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 18,652,841	$ 455,366
Accounts receivable, net of allowances of $99,278 and $100,189	2,861,014	2,217,533
Accounts receivable - related party	79,787
Royalty receivable	49,344	49,344
Inventory, net of allowance for obsolescence of $333,850 and $276,603	2,048,191	1,148,253
Prepaid and other assets	917,318	611,817
Total current assets	24,608,495	4,482,313
Long-term assets
Property and equipment, net of accumulated depreciation of $342,574 and $124,691	1,629,845	678,589
Right of use assets – operating leases	412,770	467,653
Intangible assets, net of accumulated amortization of $1,203,512 and $827,108	4,727,970	3,097,666
Investment in equity securities	5,017,351	1,100,000
Total long-term assets	11,787,936	5,343,908
Total assets	36,396,431	9,826,221
Current liabilities
Accounts payable	438,154	271,251
Accounts payable – related parties	155,817	223,589
Accrued royalties and expenses	706,196	502,191
Accrued bonus and commissions	4,518,817	2,417,277
Operating lease liability - current	203,292	125,587
Total current liabilities	6,022,276	3,539,895
Long-term liabilities
Operating lease liability – long term	222,151	355,797
Other long-term liabilities		90,293
Total long-term liabilities	222,151	446,090
Total liabilities	6,244,427	3,985,985
Commitments and contingencies (Note 6)
Shareholders’ equity
Common Stock: $0.001 par value, 20,000,000 shares authorized; 7,676,662 issued and outstanding as of December 31, 2021 and 6,297,008 issued and outstanding as of December 31, 2020	7,677	6,297
Additional paid-in capital	45,867,768	13,176,576
Accumulated deficit	(15,235,044)	(7,032,242)
Total Sanara MedTech shareholders’ equity	30,640,401	6,150,631
Equity (deficit) attributable to noncontrolling interest	(488,397)	(310,395)
Total shareholders’ equity	30,152,004	5,840,236
Total liabilities and shareholders’ equity	$ 36,396,431	$ 9,826,221